One of many benefits being a researcher is making friends with highly talented people and visiting them around the world. Last weekend was a blast! Thanks and congrats to Luca Bertamini! With JB Alberge

Wonderful to see this work from Jorge Diego Martin-Rufino and #AlexisCaulier from our lab out in #bioRxiv! Please check out our development and application of Perturb-multiome to enable systematic mapping of genetic variation impacting hematopoiesis!

ASH is redefining ANC reference ranges based on Duffy status. No patient should face uncertainty in their medical treatment because of their genetics. #ASHDEI #HealthEquity

Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors dlvr.it/TD4mf0

Excited to share our new paper focusing on Second Primary Malignancies (SPMs) following CAR T-cell therapy out today in Clinical Cancer Research ! 👇 This first-in-kind meta-analysis spans 5,517 lymphoma and myeloma patients receiving a range of CAR-T products. aacrjournals.org/clincancerres/…

We had a great ASH-FDA workshop for 2 days. Thank you FDA and ASH for a great collaborative effort to make a difference for our patients. #ash #mmsm #FDA

This week we hosted a special workshop with FDA Oncology where ASH members in academic medicine and Agency representatives learned from each other. Want to learn more and potentially join the next one? 👉ow.ly/WhEF50Tmc2Y

It was an honor to do this podcast with Charles Swanton about the rising epidemic of young-onset cancers. Take a listen below! Dana-Farber Dana-Farber News Dana-Farber's Young-Onset Colorectal Cancer Center

For managers at higher levels, success becomes more about hiring exceptional leaders, building self-reliant teams, establishing a clear vision, and communicating well. s.hbr.org/3pxPJeZ

Strong leadership and strong management are different things — but they're both necessary for success today. s.hbr.org/3XmgDdu

World-renowned soprano Renee Fleming shared her passion for harnessing music as a tool for healing with FNIH President and CEO Julie Gerberding. We are excited to partner with her on the NIH-FNIH Sound Health Music Science Fellowships Program. fnih.org/our-programs/t… NIH

Amazing night ⁦Foundation for the National Institutes of Health⁩ RENÉE Fleming Julie Gerberding. We can only make it happen if we all work together, NIH, pharma, academia. #NYC #mmsm

Back to my roots...Tuesday, 4pm, Seminars in Oncology Dana-Farber ! thanks Anthony Letai MD PhD for the invitation!

Team Science Day is here! We are thrilled to welcome esteemed partners from around the country as we explore the frontiers of biomedical science. Follow along on our social channels. #TeamScienceDay #BridgestoBreakthroughs #HealthInnovation #HealthInvesting #Philanthropy

In the Spotlight: A role for germline variants in multiple myeloma? bit.ly/3XNBrcL #MMsm #CancerGenomics

Amazing session TERRY SMITH with Monica Bertagnolli at NIH, Julie Gerberding and Hilary Marston at FDA.

New research disproves the longstanding common stereotype that women are "too emotional" to lead. s.hbr.org/4guNnID

Join me at the 2024 Biomarkers of Aging Conference, where I'll moderate the session, “Longitudinal & Clinical Biomarkers of Aging” featuring some of the very best in the field. Learn more and secure your ticket at agingconsortium.org/conference-2024. #BoAC2024 Biomarkers of Aging Consortium

Novel use of DCB angioplasty followed by stent implantation for Tx PVS or PVTO is safe & effective, w/ lower risk of restenosis & reintervention compared w/ angioplasty & stenting w/out drug delivery. Longer-term follow-up is needed bit.ly/4e7KjAA #JACCCEP #EPeeps

👇🏾👇🏾 this is huge ! We can make clinical trials truely accessible to all patients including rural & underserved communities! Really appreciate this important FDA Oncology guidance for all of us involved in clinical trials.